Inmaculada Castillo

3.3k total citations
93 papers, 2.6k citations indexed

About

Inmaculada Castillo is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Inmaculada Castillo has authored 93 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hepatology, 64 papers in Epidemiology and 17 papers in Rheumatology. Recurrent topics in Inmaculada Castillo's work include Hepatitis C virus research (76 papers), Hepatitis B Virus Studies (53 papers) and Liver Disease Diagnosis and Treatment (46 papers). Inmaculada Castillo is often cited by papers focused on Hepatitis C virus research (76 papers), Hepatitis B Virus Studies (53 papers) and Liver Disease Diagnosis and Treatment (46 papers). Inmaculada Castillo collaborates with scholars based in Spain, United States and Italy. Inmaculada Castillo's co-authors include Javier Bartolomé, Vicente Carréño, Juan Antonio Quiroga, Elena Rodríguez‐Iñigo, Sonia Navas, Juan Manuel López‐Alcorocho, V. Carreño, Margarita Pardo, V. Carreño and Juan Carlos Porres and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Inmaculada Castillo

91 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Inmaculada Castillo 2.2k 2.0k 295 235 173 93 2.6k
M. Mizokami 2.3k 1.0× 2.2k 1.1× 150 0.5× 305 1.3× 202 1.2× 72 2.7k
Y. Miyakawa 1.9k 0.8× 1.6k 0.8× 282 1.0× 189 0.8× 152 0.9× 7 2.0k
J. Guardia 1.9k 0.9× 1.7k 0.9× 186 0.6× 302 1.3× 158 0.9× 38 2.2k
Kiyohiko Kurai 2.0k 0.9× 1.7k 0.8× 331 1.1× 175 0.7× 170 1.0× 17 2.1k
Paul Neuwald 1.7k 0.8× 1.7k 0.8× 307 1.0× 409 1.7× 181 1.0× 20 2.3k
Vicente Carréño 2.8k 1.2× 2.6k 1.3× 409 1.4× 323 1.4× 225 1.3× 117 3.6k
Juan Antonio Quiroga 1.2k 0.5× 1.1k 0.5× 189 0.6× 152 0.6× 79 0.5× 56 1.5k
Harvey J. Alter 1.9k 0.8× 1.7k 0.9× 154 0.5× 329 1.4× 139 0.8× 7 2.4k
Jacqueline C. Melpolder 2.9k 1.3× 2.6k 1.3× 212 0.7× 380 1.6× 187 1.1× 11 3.4k
Margarita Pardo 1.1k 0.5× 1.0k 0.5× 187 0.6× 229 1.0× 104 0.6× 49 1.7k

Countries citing papers authored by Inmaculada Castillo

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Castillo more than expected).

Fields of papers citing papers by Inmaculada Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Castillo. The network helps show where Inmaculada Castillo may publish in the future.

Co-authorship network of co-authors of Inmaculada Castillo

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Castillo. A scholar is included among the top collaborators of Inmaculada Castillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Castillo. Inmaculada Castillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castillo, Inmaculada, et al.. (2025). Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved. Reviews in Endocrine and Metabolic Disorders. 26(5). 815–836. 7 indexed citations
2.
Castillo, Inmaculada, et al.. (2014). [Effectiveness and safety of lenalidomide in myelofibrosis patients: a case series from the Spanish compassionate use program].. PubMed. 37(2). 135–42. 1 indexed citations
3.
Castillo, Inmaculada, Jorge Martínez-Ara, Teresa Olea, et al.. (2014). High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies. Kidney International. 86(3). 619–624. 29 indexed citations
4.
Castillo, Inmaculada, Javier Bartolomé, Jorge Quiroga, Guillermina Barril, & V. Carreño. (2009). Presence of HCV‐RNA after ultracentrifugation of serum samples during the follow‐up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection. Alimentary Pharmacology & Therapeutics. 30(5). 477–486. 9 indexed citations
5.
Berenguer, Juan, José M. Bellón, Pilar Miralles, et al.. (2007). Association between Exposure to Nevirapine and Reduced Liver Fibrosis Progression in Patients with HIV and Hepatitis C Virus Coinfection. Clinical Infectious Diseases. 46(1). 137–143. 36 indexed citations
6.
Quiroga, Juan Antonio, Inmaculada Castillo, Elena Rodríguez‐Iñigo, et al.. (2006). Virus‐specific T‐cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Journal of Medical Virology. 78(9). 1190–1197. 19 indexed citations
7.
Pardo, Margarita, Inmaculada Castillo, H Oliva, et al.. (1997). A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C. Hepatology. 26(5). 1318–1321. 23 indexed citations
8.
Quiroga, Juan Antonio, et al.. (1996). Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay. Journal of Medical Virology. 50(1). 16–19. 23 indexed citations
9.
Pardo, Margarita, Inmaculada Castillo, Sonia Navas, & V. Carreño. (1995). Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony‐stimulating factor plus recombinant interferon‐alpha. Journal of Medical Virology. 45(4). 439–444. 16 indexed citations
10.
Castillo, Inmaculada, et al.. (1995). Hepatitis C Virus Genotypes in Serum and Liver of Children with Chronic Hepatitis C. Pediatric Research. 38(4). 618–620. 8 indexed citations
11.
12.
13.
Madejón, Antonio, et al.. (1993). Significance of low HDV replication levels during the natural history of HDV infection. Journal of Hepatology. 17. S157–S160. 2 indexed citations
14.
Moraleda, Gloria, et al.. (1993). Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole. Journal of Hepatology. 19(3). 437–441. 6 indexed citations
15.
Navas, Sonia, Jorge del Romero, Soledad García, et al.. (1993). Treatment with recombinant α‐interferon of chronic hepatitis C in anti‐HIV‐positive patients. Journal of Medical Virology. 40(2). 107–111. 70 indexed citations
16.
Carreño, V., Luis Tapia, Jean‐Charles Ryff, Juan Antonio Quiroga, & Inmaculada Castillo. (1992). Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon‐alpha. Journal of Medical Virology. 37(3). 215–219. 15 indexed citations
17.
Castillo, Inmaculada, Javier Bartolomé, Juan Antonio Quiroga, & Vicente Carréño. (1992). Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome. Journal of Virological Methods. 38(1). 71–79. 50 indexed citations
18.
Moraleda, Gloria, et al.. (1991). Analysis of hepatitis B virus DNA, liver disease and influence of antibody to hepatitis C virus in anti‐HBe chronic carriers. Liver International. 11(6). 352–357. 4 indexed citations
19.
Castillo, Inmaculada, Javier Bartolomé, Juan Antonio Quiroga, Juan Carlos Porres, & Vicente Carréño. (1990). Detection of HBeAg/anti‐HBe immune complexes in the reactivation of hepatitis B virus replication among anti‐HBe chronic carriers. Liver International. 10(2). 79–84. 18 indexed citations
20.
Madejón, Antonio, Inmaculada Castillo, Javier Bartolomé, et al.. (1990). Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection. Journal of Hepatology. 11(3). 381–384. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Mizokami Breakdown of academic impact, for papers by Y. Miyakawa Breakdown of academic impact, for papers by J. Guardia Breakdown of academic impact, for papers by Kiyohiko Kurai Breakdown of academic impact, for papers by Paul Neuwald Breakdown of academic impact, for papers by Vicente Carréño Breakdown of academic impact, for papers by Juan Antonio Quiroga Breakdown of academic impact, for papers by Harvey J. Alter Breakdown of academic impact, for papers by Jacqueline C. Melpolder Breakdown of academic impact, for papers by Margarita Pardo
Rankless by CCL
2026